Study of the safety and efficacy of daily oral antiretroviral use for the prevention of HIV infection in heterosexually active young adults in Botswana

Trial Profile

Study of the safety and efficacy of daily oral antiretroviral use for the prevention of HIV infection in heterosexually active young adults in Botswana

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Aug 2016

At a glance

  • Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
  • Indications HIV-1 infections
  • Focus Adverse reactions; Registrational; Therapeutic Use
  • Acronyms TDF2
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 16 Dec 2015 Results of sub-group analysis (n=4) published in the JAIDS
    • 11 Jul 2012 Results published in the New England Journal of Medicine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top